ArticleCancers2021

Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa Study.

Nicolai Grønne Jørgensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.